The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43
Open accessAbstract
Accumulation of phosphorylated cytoplasmic TDP-43 inclusions accompanied by loss of normal nuclear TDP-43 in neurons and glia of the brain and spinal cord are the molecular hallmarks of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP). However, the role of cytoplasmic TDP-43 in the pathogenesis of these neurodegenerative TDP-43 proteinopathies remains unclear, due in part to a lack of valid mouse models. We therefore generated new mice with doxycycline (Dox)-suppressible expression of human TDP-43 (hTDP-43) harboring a defective nuclear localization signal (∆NLS) under the control of the neurofilament heavy chain promoter. Expression of hTDP-43∆NLS in these ‘regulatable NLS’ (rNLS) mice resulted in the accumulation of insoluble, phosphorylated cytoplasmic TDP-43 in brain and spinal cord, loss of endogenous nuclear mouse TDP-43 (mTDP-43), brain atrophy, muscle denervation, dramatic motor neuron loss, and progressive motor impairments leading to death. Notably, suppression of hTDP-43∆NLS expression by return of Dox to rNLS mice after disease onset caused a dramatic decrease in phosphorylated TDP-43 pathology, an increase in nuclear mTDP-43 to control levels, and the prevention of further motor neuron loss. rNLS mice back on Dox also showed a significant increase in muscle innervation, a rescue of motor impairments, and a dramatic extension of lifespan. Thus, the rNLS mice are new TDP-43 mouse models that delineate the timeline of pathology development, muscle denervation and neuron loss in ALS/FTLD-TDP. Importantly, even after neurodegeneration and onset of motor dysfunction, removal of cytoplasmic TDP-43 and the concomitant return of nuclear TDP-43 led to neuron preservation, muscle re-innervation and functional recovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,417
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Self-citationMotor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Self-citationConverging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811 · cited 1×
“Moreover, many of these animals do not develop a progressive ALS-like phenotype, which is a requirement for future preclinical testing of ALS therapeutics [29].”
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Huelga, S. C., Moran, J., Liang, T. Y., Ling, S.-C., Sun, E., Wancewicz, E., Mazur, C., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2779 · Cited by 1,335
Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis
Brettschneider, J., Del Tredici, K., Toledo, J. B., Robinson, J. L., Irwin, D. J., Grossman, M., Suh, E., Van Deerlin, V. M., Wood, E. M., Baek, Y., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23937 · Cited by 1,065
Self-citationDistinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies
Sanders, D. W., Kaufman, S. K., DeVos, S. L., Sharma, A. M., Mirbaha, H., Li, A., Barker, S. J., Foley, A. C., Thorpe, J. R., Serpell, L. C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.04.047 · Cited by 986
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M., & Baloh, R. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908767106 · Cited by 706
Proteopathic tau seeding predicts tauopathy in vivo
Holmes, B. B., Furman, J. L., Mahan, T. E., Yamasaki, T. R., Mirbaha, H., Eades, W. C., Belaygorod, L., Cairns, N. J., Holtzman, D. M., & Diamond, M. I. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411649111 · Cited by 696 · cited 2×
“For example, misfolded tau and α-synuclein induce disease spread in vivo and cause pathology reminiscent of Alzheimer’s and Parkinson’s diseases, respectively [15, 16, 19, 21, 38].”
Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B., Riddle, D. M., Kwong, L. K., Xu, Y., Trojanowski, J. Q., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.057 · Cited by 680
Self-citationIba, M., Guo, J. L., McBride, J. D., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2642-12.2013 · Cited by 664 · cited 2×
“For example, misfolded tau and α-synuclein induce disease spread in vivo and cause pathology reminiscent of Alzheimer’s and Parkinson’s diseases, respectively [15, 16, 19, 21, 38].”
Self-citationGains or losses: molecular mechanisms of TDP43-mediated neurodegeneration
Lee, E. B., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3121 · Cited by 659 · cited 2×
“TDP-43 is a widely expressed and highly conserved protein with diverse functions in RNA metabolism, including RNA translation, splicing and transport [26].”
Self-citationCell-to-cell transmission of pathogenic proteins in neurodegenerative diseases
Guo, J. L., & Lee, V. M. Y. (2014) · Nature Medicine · doi:10.1038/nm.3457 · Cited by 641
Self-citationTDP‐43 regulates its mRNA levels through a negative feedback loop
Ayala, Y. M., De Conti, L., Avendaño‐Vázquez, S. E., Dhir, A., Romano, M., D'Ambrogio, A., Tollervey, J., Ule, J., Baralle, M., Buratti, E., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.310 · Cited by 637
Structural determinants of the cellular localization and shuttling of TDP-43
Ayala, Y. M., Zago, P., D'Ambrogio, A., Xu, Y.-F., Petrucelli, L., Buratti, E., & Baralle, F. E. (2008) · Journal of Cell Science · doi:10.1242/jcs.038950 · Cited by 630
Self-citationNeumann, M., Kwong, L. K., Lee, E. B., Kremmer, E., Flatley, A., Xu, Y., Forman, M. S., Troost, D., Kretzschmar, H. A., Trojanowski, J. Q., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0477-9 · Cited by 604
Self-citationWils, H., Kleinberger, G., Janssens, J., Pereson, S., Joris, G., Cuijt, I., Smits, V., Ceuterick-de Groote, C., Van Broeckhoven, C., & Kumar-Singh, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912417107 · Cited by 587
Amyotrophic lateral sclerosis—a model of corticofugal axonal spread
Braak, H., Brettschneider, J., Ludolph, A. C., Lee, V. M., Trojanowski, J. Q., & Tredici, K. D. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.221 · Cited by 527
Self-citationPrion-like Properties of Pathological TDP-43 Aggregates from Diseased Brains
Nonaka, T., Masuda-Suzukake, M., Arai, T., Hasegawa, Y., Akatsu, H., Obi, T., Yoshida, M., Murayama, S., Mann, D. M. A., Akiyama, H., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.007 · Cited by 521
Arnold, E. S., Ling, S.-C., Huelga, S. C., Lagier-Tourenne, C., Polymenidou, M., Ditsworth, D., Kordasiewicz, H. B., McAlonis-Downes, M., Platoshyn, O., Parone, P. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222809110 · Cited by 492
Lee, V., Carden, M., Schlaepfer, W., & Trojanowski, J. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-11-03474.1987 · Cited by 490
Self-citationTAR DNA-binding protein 43 in neurodegenerative disease
Chen-Plotkin, A. S., Lee, V. M.-Y., & Trojanowski, J. Q. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.18 · Cited by 468
Self-citationDysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice
Igaz, L. M., Kwong, L. K., Lee, E. B., Chen-Plotkin, A., Swanson, E., Unger, T., Malunda, J., Xu, Y., Winton, M. J., Trojanowski, J. Q., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44867 · Cited by 434
Self-citationAutophagy induction enhances TDP43 turnover and survival in neuronal ALS models
Barmada, S. J., Serio, A., Arjun, A., Bilican, B., Daub, A., Ando, D. M., Tsvetkov, A., Pleiss, M., Li, X., Peisach, D., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1563 · Cited by 431
Wang, I.-F., Guo, B.-S., Liu, Y.-C., Wu, C.-C., Yang, C.-H., Tsai, K.-J., & Shen, C.-K. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206362109 · Cited by 377
TDP-43 Is a Developmentally Regulated Protein Essential for Early Embryonic Development
Sephton, C. F., Good, S. K., Atkin, S., Dewey, C. M., Mayer, P., Herz, J., & Yu, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.061846 · Cited by 370
Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis
Kraemer, B. C., Schuck, T., Wheeler, J. M., Robinson, L. C., Trojanowski, J. Q., Lee, V. M. Y., & Schellenberg, G. D. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0659-0 · Cited by 350 · cited 1×
“Complete knockout of TDP-43 in mice is embryonic lethal [24, 40, 50], and ubiquitous inducible post-natal Cre recombinase-mediated deletion of TDP-43 in mice causes alterations in fat metabolism and death within 9 days [11].”
Self-citationIgaz, L. M., Kwong, L. K., Xu, Y., Truax, A. C., Uryu, K., Neumann, M., Clark, C. M., Elman, L. B., Miller, B. L., Grossman, M., et al. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080003 · Cited by 327
Self-citationSampathu, D. M., Neumann, M., Kwong, L. K., Chou, T. T., Micsenyi, M., Truax, A., Bruce, J., Grossman, M., Trojanowski, J. Q., & Lee, V. M.-Y. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060438 · Cited by 322
Self-citationSequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD)
Brettschneider, J., Del Tredici, K., Irwin, D. J., Grossman, M., Robinson, J. L., Toledo, J. B., Fang, L., Van Deerlin, V. M., Ludolph, A. C., Lee, V. M.-Y., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1238-y · Cited by 312
Self-citationGeser, F., Brandmeir, N. J., Kwong, L. K., Martinez-Lage, M., Elman, L., McCluskey, L., Xie, S. X., Lee, V. M.-Y., & Trojanowski, J. Q. (2008) · Archives of Neurology · doi:10.1001/archneur.65.5.636 · Cited by 306
Self-citationDeletion of TDP-43 down-regulates Tbc1d1 , a gene linked to obesity, and alters body fat metabolism
Chiang, P.-M., Ling, J., Jeong, Y. H., Price, D. L., Aja, S. M., & Wong, P. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002176107 · Cited by 302
Scotter, E. L., Vance, C., Nishimura, A. L., Lee, Y.-B., Chen, H.-J., Urwin, H., Sardone, V., Mitchell, J. C., Rogelj, B., Rubinsztein, D. C., et al. (2014) · Journal of Cell Science · doi:10.1242/jcs.140087 · Cited by 268
Clinical and Pathological Continuum of Multisystem TDP-43 Proteinopathies
Geser, F., Martinez-Lage, M., Robinson, J., Uryu, K., Neumann, M., Brandmeir, N. J., Xie, S. X., Kwong, L. K., Elman, L., McCluskey, L., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.558 · Cited by 267 · cited 1×
“ALS and FTLD-TDP are therefore now considered to form a spectrum of disorders [12, 13].”
Self-citationTDP‐43, a neuro‐pathosignature factor, is essential for early mouse embryogenesis
Wu, L., Cheng, W., Hou, S., Yan, Y., Jiang, S., & Shen, C. ‐. J. (2010) · genesis · doi:10.1002/dvg.20584 · Cited by 256
Toledo, J. B., Van Deerlin, V. M., Lee, E. B., Suh, E., Baek, Y., Robinson, J. L., Xie, S. X., McBride, J., Wood, E. M., Schuck, T., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.06.003 · Cited by 234 · cited 1×
“Human tissues were obtained at autopsy and processed for neuropathological assessment as described previously [43].”
MethodSelf-citationTsai, K.-J., Yang, C.-H., Fang, Y.-H., Cho, K.-H., Chien, W.-L., Wang, W.-T., Wu, T.-W., Lin, C.-P., Fu, W.-M., & Shen, C.-K. J. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092164 · Cited by 226
Higher order arrangement of the eukaryotic nuclear bodies
Wang, I.-F., Reddy, N. M., & Shen, C.-K. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212483099 · Cited by 188
Lee, V. M. ‐., Page, C. D., Wu, H. ‐., & Schlaepfer, W. W. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb09692.x · Cited by 163
Self-citationZhang, Y., Gendron, T. F., Xu, Y.-F., Ko, L., Yen, S.-H. C., & Petrucelli, L. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-33 · Cited by 163
Self-citationWu, L.-S., Cheng, W.-C., & Shen, C.-K. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.359000 · Cited by 159
Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS
Robertson, J., Sanelli, T. R., Xiao, S., Yang, W., Horne, P., Hammond, R. R., Pioro, E. P., & Strong, M. J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.03.066 · Cited by 132
Sobue, G., Hashizume, Y., Yasuda, T., Mukai, E., Kumagai, T., Mitsuma, T., & Trojanowski, J. Q. (1990) · Acta Neuropathologica · doi:10.1007/bf00308716 · Cited by 121
Self-citationPesiridis, G. S., Tripathy, K., Tanik, S. A., Trojanowski, J. Q., & Lee, V. M. ‐. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.231118 · Cited by 118
Self-citationMutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats
Huang, C., Tong, J., Bi, F., Zhou, H., & Xia, X. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59130 · Cited by 111
Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS
Shan, X., Vocadlo, D. J., & Krieger, C. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.031 · Cited by 73
TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
Turner, B. J., Bäumer, D., Parkinson, N., Scaber, J., Ansorge, O., & Talbot, K. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-104 · Cited by 65
Reversible Behavioral Phenotypes in a Conditional Mouse Model of TDP-43 Proteinopathies
Alfieri, J. A., Pino, N. S., & Igaz, L. M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1918-14.2014 · Cited by 61
How can we improve clinical trials in amyotrophic lateral sclerosis?
Gordon, P. H., & Meininger, V. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.147 · Cited by 61
Balin, B. J., Clark, E. A., Trojanowski, J. Q., & Lee, V. M. ‐. (1991) · Brain Research · doi:10.1016/0006-8993(91)90306-g · Cited by 44
Self-citationNeuron-specific expression of Cre recombinase during the late phase of brain development
Hirasawa, M., Cho, A., Sreenath, T., Sauer, B., Julien, J., & Kulkarni, A. B. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(01)00216-4 · Cited by 37
Novel monoclonal antibodies to normal and pathologically altered human TDP-43 proteins
Kwong, L. K., Irwin, D. J., Walker, A. K., Xu, Y., Riddle, D. M., Trojanowski, J. Q., & Lee, V. M. ‐. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-33 · Cited by 37
Self-citation
Cited by
Animal models of neurodegenerative diseases
Dawson, T. M., Golde, T. E., & Lagier-Tourenne, C. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0236-8 · Cited by 576
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Becker, L. A., Huang, B., Bieri, G., Ma, R., Knowles, D. A., Jafar-Nejad, P., Messing, J., Kim, H. J., Soriano, A., Auburger, G., et al. (2017) · Nature · doi:10.1038/nature22038 · Cited by 571
The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
Suk, T. R., & Rousseaux, M. W. C. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00397-1 · Cited by 450
Practical considerations for choosing a mouse model of Alzheimer’s disease
Jankowsky, J. L., & Zheng, H. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0231-7 · Cited by 449
TDP-43 Pathology in Alzheimer’s Disease
Meneses, A., Koga, S., O’Leary, J., Dickson, D. W., Bu, G., & Zhao, N. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00503-x · Cited by 363
Metadata
- Authors
- Walker, A. K., Spiller, K. J., Ge, G., Zheng, A., Xu, Y., Zhou, M., Tripathy, K., Kwong, L. K., Trojanowski, J. Q., & Lee, V. M.-Y.
- Venue
- Acta Neuropathologica
- Published
- 2015-07-22
- Volume
- 130
- Issue
- 5
- Pages
- 643-660
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W949737134
- Cited by
- 336
- References
- 53
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.